Plasma WFDC2 levels were measured using enzyme-linked immunosorbent assay in healthy donors as well as patients with gastric, lung, colorectal, esophageal, and pancreatic cancers. The gene discussed is WFDC2; the disease is familial pancreatic carcinoma.